Jonathan Tward

10PUBLICATIONS
25CO-AUTHORS
Predictive and prognostic markersEnvironment and cultureHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Oct 24, 2024
Prostate Cancer Risk Stratification in NRG Oncology Phase III Randomized Trials Using Multimodal Deep Learning With Digital Histopathology.

Jonathan David Tward, Huei-Chung Huang, Andre Esteva

|May 15, 2024
Using the Cell-Cycle Risk Score to Predict the Benefit of Androgen-Deprivation Therapy Added to Radiation Therapy in Patients With Newly Diagnosed Prostate Cancer.

Jonathan D Tward, Lauren Lenz, Alexander Gutin

|Feb 08, 2024
Validation of the Combined Clinical Cell-Cycle Risk Score to Prognosticate Early Prostate Cancer Metastasis From Biopsy Specimens and Comparison With Other Routinely Used Risk Classifiers.

Ryan J Hutten, Bismarck Odei, Skyler B Johnson

|Sep 18, 2023
Multi-Institutional Analysis of Cancer Patient Exposure, Perceptions, and Trust in Information Sources Regarding Complementary and Alternative Medicine.

Ryan J Hutten, Christopher R Weil, Andy J King

|Feb 22, 2023
Secondary malignancies in non-Hodgkin lymphoma survivors: 40 years of follow-up assessed by treatment modality.

Matthew W Parsons, Calvin Rock, Jonathan J Chipman

|Jul 12, 2021
Clinical Germline Testing Results of Men With Prostate Cancer: Patient-Level Factors and Implications of NCCN Guideline Expansion.

Samantha E Greenberg, Trevor C Hunt, Jacob P Ambrose

Pageof 2

Frequent Collaborators

2 joint publications

David K Gaffney

2 joint publications

Ryan J Hutten

2 joint publications

Skyler B Johnson

1 joint publications

Samantha E Greenberg